Protagonist Therapeutics (PTGX) Earnings Date & Reports

Industry: @Biotechnology

A.I. Advisor

published Earnings

PTGX is expected to report earnings to rise 25.66% to -62 cents per share on November 06

Protagonist Therapeutics PTGX Stock Earnings Reports

Q3'24

Est.

$-0.63

Q2'24

Beat

by $0.10

Q1'24

Beat

by $2.07

Q4'23

Beat

by $0.39

Q3'23

Beat

by $0.08

The last earnings report on August 06 showed earnings per share of -50 cents, beating the estimate of -60 cents. With 475.57K shares outstanding, the current market capitalization sits at 2.48B.

View a ticker or compare two or three

Compare

PTGX

Setup

Buy or SellView

Daily Signalchanged days ago

Gain/Loss if shorted

View Trends For PTGX
(Try 14 days for $1 only)

Ad is loading...

A.I.Advisor

published price charts

View to see Real Time Patterns for PTGX (Try 14 days for $1 only)

A.I. Advisor

published General Information

General Information

a developer of disulfide-rich peptides

Industry Biotechnology

Profile

Fundamentals

Details

Industry

Biotechnology

Address

7707 Gateway Boulevard

Phone

+1 510 474-0170

Employees

112

Web

https://www.protagonist-inc.com